Co-delivering irinotecan and imiquimod by pH-responsive micelle amplifies anti-tumor immunity against colorectal cancer.
Int J Pharm
; 648: 123583, 2023 Dec 15.
Article
in En
| MEDLINE
| ID: mdl-37940081
Full text:
1
Collection:
01-internacional
Health context:
6_ODS3_enfermedades_notrasmisibles
Database:
MEDLINE
Main subject:
Colorectal Neoplasms
/
Micelles
Limits:
Animals
Language:
En
Journal:
Int J Pharm
Year:
2023
Document type:
Article